
|Articles|December 18, 2014
- Breast Cancer (Issue 1)
- Volume 1
- Issue 1
Advances in the Treatment of HER2-Positive Breast Cancer
Author(s)William J. Gradishar, MD
William J. Gradishar, MD, discusses advances in the last year in the treatment of patients with HER2-positive breast cancer.
William J. Gradishar, MD, Betsy Bramsen Professorship of Breast Oncology, Professor in Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, discusses advances in the last year in the treatment of patients with HER2-positive breast cancer.
<<<
Articles in this issue
almost 11 years ago
Breast Ultrasound Added to Mammography Increases Cancer Detectionalmost 11 years ago
Biomarker-Driven Trial of Novel Topo-1 Inhibitor Debutedalmost 11 years ago
Anti-Androgen Not for Male Cancers Alonealmost 11 years ago
Trials Seek Optimal nab-Paclitaxel Regimen for First-Line Use in TNMBCalmost 11 years ago
Obesity as a Risk Factor for Inflammatory Breast Canceralmost 11 years ago
Immune Checkpoint Inhibition in Breast Cancer



































